Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41)

The requested reference [156c3d625a43d01f09a7f300654fb6fc8c36689c] no longer exists in our database. It has been replaced by the current reference: [78aa7070e86b3911a58cde072b2f3b7f6132c9fd]

Authors
Category Primary study
Year 2000
This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Intensive blood glucose control in patients with type 2 diabetes significantly increased treatment costs but substantially reduced the cost of complications and increased the time free of complications.
Epistemonikos ID: 8165b1e64813c11ae203ce87c914b7d7f980c779
First added on: Apr 19, 2023